Longitude Capital Partners V, LLC

Holdings History for CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Symbol
CTMX on Nasdaq
Investment type
Equity / Common Stock, $0.00001 par value per share
Latest Disclosed Shares Owned
11,538,461 shares
Security Ownership %
7.3%

Longitude Capital Partners V, LLC ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

20 May 2025 - Longitude Capital Partners V, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 11,538,461 shares of CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX). This represents 7.3% ownership of the company. This is the first filing by Longitude Capital Partners V, LLC disclosing ownership of CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX).